ZX-101A

N/A

Report date: 2024/04/02 16:54:01
NME

Base Information

Drug NameZX-101A
Drug Alias NameZX-101A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitorsPhosphatidylinositol 3 kinase gamma inhibitors
TargetsPhosphatidylinositol 3 kinase deltaPhosphatidylinositol-4,5-Bisphosphate 3 kinase gamma
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma, T-Cell, Peripheral +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing Zenshine Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Zenshine Pharmaceuticals Co Ltd
Inactive CompaniesHangzhou Zenshine Pharmaceuticals Co Ltd
Active IndicationsHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Non-Hodgkin +[5] 
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A